To confirm the relationship of EEF1A1 to this phenotype, we used HepG2 human hepatoma cells stably expressing an shRNA targeting EEF1A1, which we previously demonstrated resulted in a modest knockdown (−24%) (33). Here, EEF1A1 is linked to hepatocellular carcinoma.